Epigenesis Pharmaceuticals is an attractive opportunity for investors looking for:

A company with a strategic focus on developing inhaled respiratory medicines for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory diseases;
A large and rapidly growing market opportunity;
An experienced management team with strong capabilities in respiratory medicine and respiratory therapeutics, clinical trial design, business development, finance and administration;
An experienced Scientific Advisory Board composed of distinguished leaders in their respective fields of expertise;
An experienced Board of Directors composed of distinguished leaders in their respective fields of expertise.